ROCEPHIN

This brand name is authorized in Ecuador, Hong Kong SAR China, Ireland, Japan, Mexico, Nigeria, Singapore, South Africa, UK.

Active ingredients

The drug ROCEPHIN contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
Rocephin 250mg, 1g and 2g vials	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	15.586-3-07-05
GB	Medicines & Healthcare Products Regulatory Agency	39790, 44048, 44067
HK	Department of Health Drug Office	20188, 20190, 20195, 52844
IE	Health Products Regulatory Authority	57983, 57992
JP	医薬品医療機器総合機構	6132419F1020, 6132419F2026, 6132419G1025
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	098M84, 104M84
NG	Registered Drug Product Database	04-7302
Switch country to Nigeria in order to find specific presentations of ROCEPHIN
SG	Health Sciences Authority	00388P, 00566P
ZA	Health Products Regulatory Authority	R/20.1.1/44, R/20.1.1/45, R/20.1.1/46, R/20.1.1/47